October 21 report:
[Key Takeaway] In the short term, 1,4-butanediol is likely to exhibit a weak rebound amid bearish volatility, with prices remaining at a multi‑cycle high. Upside potential is limited, while downside momentum remains strong.
The latest available data is up to October 20, 2026, and it is recommended to refer to real-time data.
1. Average Difference Change Table
| Mean Difference Indicator | Value on 2026-10-20 | Value on 2026-10-19 | Direction of Change |
|---|---|---|---|
| 5-Day Mean Difference (D5) | -10.00 | -13.34 | + |
| 10-Day Mean Difference (D10) | -1.67 | 1.67 | - |
| 20-Day Mean Difference (D20) | 59.17 | 65.83 | - |
2. Signal Status Determination
Currently, this is a weak rebound within a choppy market, signaling a bearish bias.
3. Trend Direction Conclusion
The short-term trend is choppy and tilted bearish. Reason: The three moving averages did not all change in the same direction as the previous day, failing to meet the criteria for a clear uptrend or downtrend; this corresponds to a weak rebound with a bearish bias—(+, −, −). Coupled with sluggish downstream terminal demand for PBAT and other products, and weakening cost‑driven support at the upstream end, there is no sustained upward momentum in the near term.
4. Position Spatial Reference
60 days, 3 months, and 1 year cycle prices are all in the 5th tier (high) out of 5 tiers, with the overall upward potential already exhausted, leaving ample room for subsequent declines.
5. Trend Chart Display
6. Risk Warning
The above analysis is for reference only and does not constitute trading advice.
